NVO vs GILD: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Gilead Sciences Inc in 2026
NVO
Novo Nordisk A S
$45.51
GILD
Gilead Sciences Inc
$136.22
Key Metrics Comparison
| Metric | NVO | GILD | Winner |
|---|---|---|---|
| Market Cap | $197.39B | $165.99B | NVO |
| P/E Ratio | 10.43 | 18.19 | NVO |
| EPS (TTM) | $4.27 | $7.35 | GILD |
| Revenue Growth | 0.2% | 0.0% | NVO |
| Gross Margin | 83.2% | 79.4% | NVO |
Analyze NVO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or GILD a better investment?
Comparing NVO and GILD: Novo Nordisk A S has a market cap of $197.39B while Gilead Sciences Inc has $165.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and GILD?
NVO (Novo Nordisk A S) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or GILD?
Based on P/E ratios, NVO trades at a lower multiple (10.4x vs 18.2x).
Which is growing faster: NVO or GILD?
NVO has higher revenue growth at 0.2% vs 0.0% for GILD.
Which company is more profitable: NVO or GILD?
Novo Nordisk A S (NVO) has higher gross margins at 83.2% compared to 79.4% for GILD.
Which is the larger company: NVO or GILD?
Novo Nordisk A S (NVO) is larger with a market cap of $197.39B compared to $165.99B for GILD.
Should I buy NVO or GILD in 2026?
Both NVO and GILD have investment merit. NVO trades at $45.51 while GILD trades at $136.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and GILD stock?
Key differences: Market Cap ($197.39B vs $165.99B), P/E Ratio (10.4x vs 18.2x), Revenue Growth (0.2% vs 0.0%), Gross Margin (83.2% vs 79.4%).